| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Institute for Hormone and Fertility Research (R.I., M.B., R.J.K.A., H.-J.P.), University of Hamburg, 22529 Hamburg, Germany; and Medical Research Council (C.M., R.S.) Centre for Human Reproductive Science, Edinburgh EH16 4SB, United Kingdom
Address all correspondence and requests for reprints to: Richard Ivell, Institute for Hormone and Fertility Research, University of Hamburg, Falkenried 88, 20251 Hamburg, Germany. E-mail: ivell{at}ihf.de
| Abstract |
|---|
|
|
|---|
-androstanediol into dihydrotestosterone, and estradiol to estrone. Thus, perinatal expression of this enzyme in fetal Leydig cells may contribute to protecting these cells from estrogens and encourage androgen formation. | Introduction |
|---|
|
|
|---|
-reductase, in target tissues, to the more potent dihydrotestosterone (DHT), comparatively little is known about their catabolism to less active metabolites. Within the testis, the local action of catabolic enzymes like the 17ß-hydroxysteroid dehydrogenases (17ß-HSDs), type2 and type 4, may be important to protect testicular cells from excessive androgen levels (1, 2). Together with steroid-binding globulins, these enzymes supposedly regulate the amounts of androgens available to activate intratesticular androgen receptors.
Recently, a new member of the short-chain alcohol dehydrogenase family was described, originally in the context of Alzheimer disease, as a brain factor (endoplasmic reticulum-associated amyloid-binding protein, ERAB) linked to neurotoxicity (3). Further biochemical characterization of the recombinant enzyme showed it to be a novel member of the large family of 17ß-HSDs now referred to as 17ß-HSD, type 10 (17ß-HSD-10) (4, 5, 6, 7). Interestingly, although estradiol and other 17ß-hydroxysteroids can act as substrates with 17ß-HSD-10, removing estradiol approximately as effectively as type 4 17ß-HSD (7), by far the highest affinity is seen for 3
-androstanediol (3
-diol), converting this efficiently into DHT (5, 7). Thus, the principal role for such an enzyme, besides removing estradiol, could be to protect DHT from catabolism to less active metabolites. Unlike other 17ß-HSD members, 17ß-HSD-10 seems to be a mitochondrial protein (7), though encoded by a nuclear gene (human, chromosome Xp11.21; mouse, chromosome 9) and thus, when expressed in steroidogenic cells, is likely to influence steroidogenesis at source. The gene for 17ß-HSD-10 encodes a 27-kDa protein, which in vivo forms 108-kDa homotetramers (7). It seems to be a multifunctional enzyme and, like other members of the short-chain hydroxyacyl-coenzyme A (CoA) dehydrogenase family, also exhibits fatty acid ß-oxidation properties (4, 7), which may be physiologically relevant, given its presumed mitochondrial location.
From an earlier differential cloning project, we were able to show that gene transcripts for 17ß-HSD-10 (previously referred to as ERAB) were highly expressed in the mouse testis (8) and seemed to be preferentially up-regulated in the Leydig cells of the azoospermic w/wv mouse. The localization in Leydig cells was indirect, being deduced from an enrichment of the transcript hybridization by Northern blotting in primary Leydig cells, compared with intact testis. In the present study, we have made use of a newly available antibody, raised against 17ß-HSD-10, to make a detailed study of the expression of this enzyme in the testes of different mammals, at different times of development and under different perturbation regimes, including also the effect of aging, with a view to reaching an understanding of its possible role in male reproductive function.
| Materials and Methods |
|---|
|
|
|---|
RNA extraction and analysis
Rat tissues and cells were extracted by a one-step procedure, using a phenol-free, filter-based RNA isolation system (RNAqueous) according to the instructions of the manufacturer (AMS Biotechnology, Wiesbaden, Germany). RNA electrophoresis was carried out using the standard formaldehyde/4-morpholinepropanesulfonic acid procedure (15), and RNA was transferred by 4 h capillary transfer to nylon membranes (Nytran; Schleicher \|[amp ]\| Schuell, Inc., Dassel, Germany). These were hybridized, again using standard procedures (15), to a radioactively labeled full-length cDNA insert of the mouse 17ß-HSD-10 (ERAB) gene, exactly as previously described (8). Even loading of RNA samples was checked by assessment of the ethidium bromide staining of the 28S ribosomal RNA band. Additional Northern blots were performed comparing whole testis, seminiferous tubules, and percoll-purified Leydig cells from young and old rats, loading 12 µg total RNA from each of three independent samples in each category, together on single gels. Each Leydig cell sample comprised a pool from four different animals. For quantification of the autoradiographs, these were densitometrically scanned and subjected to analysis using ImageQuant 5.0 software (Amersham International Biosciences, Freiburg, Germany), normalizing using the intensity of the ethidium bromide-stained 28S ribosomal RNA band. Results were expressed as arbitrary units, setting the mean of the values for cells and tissues from young rats at 100. Data are expressed as means ± SDs, and statistical significance is estimated by Students t test.
Protein extraction and immunological analysis
For Western blotting, Leydig cells were washed once with cold PBS and homogenized in cell lysis buffer containing 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM ß-glycerophosphate, 1 mM Na2VO4, 1 µg/ml Leupeptin, and 1 mM PMSF (Cell Signaling Technology, Beverly, MA). Ten-percent tissue homogenates were also prepared in the same cell lysis buffer. Protein concentration was determined by the Bradford assay (Bio-Rad Laboratories, Inc., München, Germany). Equal amounts (40 µg) of the resulting protein extracts were subjected to SDS-PAGE in 10% gels and transferred to positively charged polyvinylidene difluoride membranes (Amersham International Biosciences) for 2 h at 168 V. Membranes were blocked with buffer containing 1x Tris-buffered saline, 0.1% Tween-20, and 5% nonfat dry milk and incubated at room temperature for 1 h. For immunodetection of 17ß-HSD-10, membranes were incubated for 24 h at 4 C with rabbit antihuman 17ß-HSD-10 affinity-purified antibody (BioTrend Chemicals, Köln, Germany) diluted 1:1000. This antibody had been shown by the manufacturer to specifically recognize a 14-amino-acid peptide sequence (designated ERAB12) from the middle portion of mouse ERAB (17ß-HSD-10), a sequence that is 100% identical with the equivalent region of the human sequence. Membranes were then washed, incubated with goat antirabbit horseradish peroxidase-conjugated antibody (1:2000) and antibiotin antibody (1:1000), both obtained from Cell Signaling Technology, for 1 h at room temperature. After washing, the signal was detected using the Lumiglo reagent (Cell Signaling Technology). To check the loading of the samples, membranes were stripped, washed, blocked with blocking buffer (as above), and incubated overnight at 4 C with monoclonal anti-ß-actin antibody (Sigma) diluted 1:8000. The membrane was washed, and then incubated at room temperature for 1 h with horseradish peroxidase-linked antimouse IgG (1:5000; Jackson ImmunoResearch Laboratories, Inc., West Grove, PA), and the signal was detected using chemiluminescence reagent (Pierce Chemical Co. Biotechnology, Rockford, IL). As for the Northern blots, Western blots were also repeated for triplicate independent samples of whole testis, seminiferous tubules, and Leydig cells from young and old rats, with the Leydig cells being derived from 4 rats for each sample (40 µg protein was loaded per sample). Specific signals were quantified using ImageQuant software, normalizing using the ß-actin chemiluminescent intensity, and expressed as arbitrary units, with the mean of the values for the cells and tissues from young rats set at 100. Data are expressed as means ± SDs, and statistical significance is estimated by Students t test.
Immunohistochemistry of 6- to 8-µm sections of Bouins-fixed tissues, embedded in paraffin, followed the method described in Balvers et al. (10), using a double PAP-ABC (phosphatase antiphosphataseavidin-biotin-complex) procedure. For most tissues, the primary antibody (see above) was applied at a dilution of 1:100. As negative control, an equivalent amount of control rabbit IgG (Vector Laboratories, Inc., Burlingame, CA) was applied. For the semiquantitative assessment of epitope intensity in the rats subjected to various perinatal treatment regimes, preliminary experiments were carried out to show that, even for the highest local concentration of epitopes, the primary antibody was not saturating, and hence, a gradation of staining intensity could be obtained. All final immunohistochemistry was carried out in parallel under identical conditions. For these sections, 17ß-HSD-10 protein expression was estimated by counting all hemalum-stained interstitial cell nuclei (including Leydig cells and their precursor mesenchymal cells, fibroblasts, and macrophages, but excluding endothelial cells) within a defined frame of view (0.4 x 0.5 mm2), for three randomly chosen frames per tissue section and animal, for a total of three to four animals per experimental data-point and, of these, counting those with clearly positive immunostaining for 17ß-HSD-10 epitopes. Results were expressed as the percentage (mean ± SD) of positively staining interstitial cells. In addition, a subjective estimate of staining intensity of positive cells was made on a scale of: 0, no staining; I, just detectable staining; II, moderate staining; to III, heavy staining. Where groups of fetal Leydig cells were still readily identifiable in the postnatal rat testis, these were also noted. All sections were blinded before assessment by an independent observer.
| Results |
|---|
|
|
|---|
|
|
|
Unlike the other mammals that have been assessed, rats uniquely also exhibit marked immunostaining for 17ß-HSD-10 within the seminiferous tubules, in the postmeiotic stages of spermiogenesis (Fig. 2
). This does not seem to be a staining artifact, because both Northern (Fig. 3
) and Western (Fig. 4
) analyses confirm the presence of the mRNA and a weak 27-kDa protein, respectively, in rat tubules. Nevertheless, both in the rat and the mouse, within the gonad, the Leydig cells seem to be the major site of the enzyme synthesis, because both mRNA and protein are greatly enriched in primary Leydig cell preparations, compared with whole testis.
|
|
Effect of aging on 17ß-HSD-10 expression in the rat testis
Immunohistochemical assessment of rat testis sections for 17ß-HSD-10 expression showed that there is a massive reduction in staining intensity in the Leydig cells of old (23 months), compared with young (60 d), rat testes (Fig. 2
). There seems to be no effect of age on the expression of 17ß-HSD-10 within the seminiferous tubules. This was further analyzed by Northern and Western analyses. In the rat, no differences were seen in the hybridization intensity of 17ß-HSD-10 transcripts between young (3 months) and old (23 months) rats for a variety of tissues (heart, adrenal glands, testes) and testicular components (tunica albuginea, seminiferous tubules; testicular blood vessels) (Fig. 3
). However, comparing young and old Leydig cells did indeed show that the former had a significantly greater hybridization intensity (P < 0.001; Fig. 5
). Western blotting gave similar results (Figs. 4
and 5
): whereas triplicate samples of whole testis and seminiferous tubules showed no significant effect of age on the amounts of immunoreactive protein (data not shown), for Leydig cells there was a marked difference (P < 0.001) between young and old rats in the staining intensity of the specific 27-kDa band (Fig. 5
).
|
| Discussion |
|---|
|
|
|---|
-diol as substrate, followed by estradiol and other 17ß-hydroxysteroids (4, 5). Here, we show that it has a highly conserved expression in the Leydig cells of all mammals so far tested, confirming at the protein level what was suggested previously at the mRNA level for the mouse (8). These results are additionally supported by a recent study in which 17ß-HSD activity, with a preference for 3
-diol as substrate and high expression in fetal Leydig cells, was shown enzyme-histochemically in the Leydig cells of the rat testis (18). The present study shows first that 17ß-HSD-10 is an important product of the fetal population of Leydig cells, continuing to be expressed at a time-point postnatally when functionally the fetal Leydig cells have begun to involute, no longer producing large amounts of steroids (19, 20). Indeed, it would seem that 17ß-HSD-10 could be a useful marker for tracing the fate of this population of Leydig cells through postnatal development, with the evidence here supporting the notion that these cells do not all enter apoptosis and degenerate (21) but can persist in later puberty as discrete clumps (22, 23). This apparent persistence of 17ß-HSD-10 expression in involuting Leydig cells is also observed in the adult hamster testis (Fig. 2In the adult population of Leydig cells, 17ß-HSD-10 begins to be expressed at about d 2025 in the postnatal rat, increasing in immunostaining intensity up to adulthood. Postnatal treatment with a GnRH antagonist causes a delay in Leydig cell growth and differentiation, reflected by reduced testosterone production (13), but Leydig cell numbers and differentiation catch up by adulthood (13). The appearance of 17ß-HSD-10 immunostaining reflects this delayed onset of cell differentiation, though catching up by d 35. Treatment of rats postnatally with low or high doses of estrogens is known to perturb Leydig cell growth and differentiation in a dose-dependent manner (12, 13, 25). As shown here, at the higher dose of DES, the expression of 17ß-HSD-10 accurately reflects the DES-dependent retardation of adult Leydig cell numbers and function (13). Interestingly, at the lower dose of DES, whereas there is no apparent influence of the estrogen on the final intensity of 17ß-HSD-10 expression on d 35 and 90, there was a significant induction of 17ß-HSD-10 expression on d 18. This correlates with an observed increase in circulating testosterone at this time in these animals (13), and perhaps indicates some advance in the functional differentiation of the adult Leydig cell population. In primary cell culture, 17ß-HSD-10 expression does not seem to be affected by acute (3-h) stimulation with the effectors 8Br-cAMP or hCG, thus excluding a rapid regulation like that for steroidogenic acute regulatory gene transcripts. Though longer incubation times were not tested, these results suggest that the 17ß-HSD-10 gene is probably regulated in a differentiation-dependent manner, rather than acutely by hormonal influences.
The rat seems to be atypical, in that 17ß-HSD-10 immunoreactivity is also observed in postmeiotic germ cells within the seminiferous tubules. Because this is seen neither in the mouse, hamster, nor any other mammal studied, this result should be regarded with caution. This is presumably an evolutionarily recent event and may be without physiological significance. Such an observation would reinforce the views of those proponents of the notion that much postmeiotic gene expression is not of functional significance but rather reflects promiscuous transcription of the unwinding haploid genome (26). Alternatively, it may be significant that, according to the Western blot analysis, the absolute concentrations of 17ß-HSD-10 in the whole rat testis are markedly lower than those in the mouse or in the human gonad, and that possibly the de novo expression in the seminiferous tubules is an attempt to redress this deficit. Given that aromatase can also be detected in postmeiotic germ cells of both the rat and the human (27, 28), 17ß-HSD-10 is possibly involved in regulating estradiol in this testicular compartment (see below). 17ß-HSD-10 is also expressed in other organs of the body, including the liver, brain, adrenal gland, skeletal muscle, lung, and heart (7, 8, 17); and hence, it is not unexpected to detect expression also in blood vessels and in the tunica albuginea of the rat testis. However, based on the immunohistochemical results, the contribution from these somatic components to enzyme activity in the testis is likely to be relatively small, compared with that of the Leydig cells.
In the male, aging is associated with a decline in circulating androgen levels, attributable to a decrease in the steroidogenic capacity of the testis; in particular, of the Leydig cells (29). Most studies on the aging male have focused on steroid biosynthesis. Here, we have been able to assess the influence of age on a quantitatively important steroid metabolizing enzyme and have shown, for the rat, that there is a marked decrease in transcript level, but most especially in protein level, assessed both by Western blot and by immunohistochemistry, of 17ß-HSD-10. This effect is very specific to Leydig cells, because it was observed in no other testicular component or for any other organ examined.
17ß-HSD-10 is probably a multifunctional enzyme, with both 17ß-HSD and acyl-CoA dehydrogenase properties (6, 30). It is located in the mitochondria, also of Leydig cells (not shown). Given this location and possible functions, then, in Leydig cells, it would seem to be an important synthetic enzyme encouraging the formation of DHT from its precursor and degradation metabolite 3
-diol. It could also, though to a lesser extent, convert androsterone to androstanedione (5). Theoretically, these pathways would all act to increase the androgenic potential of the Leydig cells; and conversely, its reduction in old age would exacerbate any age-associated hypoandrogenemia. 17ß-HSD-10 thus seems to have a role similar to that of the type 2 retinol dehydrogenase, which is also present in Leydig cells (31). 17ß-HSD-10 is also able preferentially to convert estradiol to its inactive metabolite estrone (6). Given the high immunostaining intensity in fetal Leydig cells, this could imply that 17ß-HSD-10 offers another mechanism whereby the Leydig cells are able to protect themselves from excessive estrogen influence in the pre- and immediately postnatal period, where estrogens may have marked and long-lasting disruptive effects on testis metabolism. Thus, 17ß-HSD-10 could act in a way similar to that of estrogen sulfotransferase, whose genetic deletion in mice leads to severe impairment of spermatogenesis (32). In this context, this would suggest that 17ß-HSD-10 itself might be yet another target for putative environmental disrupting agents, because a loss of its activity would potentiate the effects of any estrogens on the testis, as well as reducing local androgen activity, in the critical early phase of testis development. To date, there is no information on mammals with a mutated 17ß-HSD-10 or specifically reduced enzyme function. However, mutation of the homologous gene, scully, in Drosophila suggests an important role for this gene product in germ line formation and gonadal development (33).
| Acknowledgments |
|---|
| Footnotes |
|---|
Abbreviations: CoA, Coenzyme A; DES, diethylstilbestrol; DHT, dihydrotestosterone; 3
-diol, 3
-androstanediol; ERAB, endoplasmic reticulum-associated amyloid-binding protein; hCG, human chorionic gonadotropin; HSD, hydroxysteroid dehydrogenase; hpg, hypogonadal; 17ß-HSD-10, 17ß-HSD (type 10); RLF, relaxin-like factor.
Received November 26, 2002.
Accepted for publication March 17, 2003.
| References |
|---|
|
|
|---|
5-
4 isomerase (3-ß-HSD) in rat testis as studied by immunocytochemistry. Anat Embryol (Berl) 187:583589[CrossRef][Medline]
-hydroxysteroid dehydrogenase activity of rat Leydig cells as type II retinol dehydrogenase. Endocrinology 141:16081617This article has been cited by other articles:
![]() |
R. Ivell and R. Anand-Ivell Biology of insulin-like factor 3 in human reproduction Hum. Reprod. Update, July 1, 2009; 15(4): 463 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Takeuchi, N. Mukai, T. Tateishi, and S. Miyakawa Production of sex steroid hormones from DHEA in articular chondrocyte of rats Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E410 - E415. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. De Rienzo, F. Aniello, M. Branno, G. Izzo, and S. Minucci The expression level of frog relaxin mRNA (fRLX), in the testis of Rana esculenta, is influenced by testosterone J. Exp. Biol., October 1, 2006; 209(19): 3806 - 3811. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J.K. Anand-Ivell, V. Relan, M. Balvers, I. Coiffec-Dorval, M. Fritsch, R. A.D. Bathgate, and R. Ivell Expression of the Insulin-Like Peptide 3 (INSL3) Hormone-Receptor (LGR8) System in the Testis Biol Reprod, May 1, 2006; 74(5): 945 - 953. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |